Lung rehab for advanced lung cancer on maintenance therapy
Part of Cancer clinical trials.
This study tests if a respiratory (breathing) rehabilitation program can improve quality of life for people with advanced non-small cell lung cancer who are on maintenance treatment after initial chemotherapy and immunotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IV (advanced) non-small cell lung cancer.
- You have finished initial chemotherapy combined with immunotherapy and are now in the maintenance phase of treatment.
- You are 18 years or older.
- You are able to take care of yourself (ECOG performance status 0 or 1).
- You have no medical reasons that prevent you from doing breathing exercises or rehabilitation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a pulmonary rehabilitation program—special exercises and breathing training—to help people with advanced lung cancer feel less short of breath and improve their daily function and quality of life.
This trial studies if a rehabilitation program can help patients with advanced non-small cell lung cancer that has been stable for at least 6 months. It aims to improve physical activity and reduce symptoms.
This study tests whether a structured outpatient exercise program can help people with non-small cell lung cancer who are already receiving immunotherapy. It is designed for those whose cancer is stable or responding after initial treatment.
This trial studies whether a structured breathing and activity program (pulmonary rehabilitation) can help people with advanced non-small-cell lung cancer. It may help improve breathing and daily function alongside standard cancer treatment.
This trial looks at how well people with lung cancer stick with a respiratory rehabilitation program (breathing exercises and support). Researchers want to see if factors like your treatment stage or daily function affect your ability to keep up with rehab. It may help find ways to better support patients during recovery.
This trial tests whether giving immune therapy maintenance for a shorter time helps people with stage IV non-small cell lung cancer (NSCLC) who are doing well after initial chemo-immunotherapy. It aims to keep the cancer controlled while possibly reducing treatment exposure and side effects.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.